.3M hernia repairs in the US annually – one of the most common surgeries. $1B U.S. market for hernia repair devices. 9% growth supported by aging population and obesity epidemic
Exogenesis Corporation is commercializing proprietary nanoscale surface modification and control technology which has application in improving the safety and performance of implantable medical devices.
Surface treatment with the NanoAccelTM surface modification process* leads to accelerated cell attachment and proliferation which in turn leads to enhanced tissue integration